Results 131 to 140 of about 41,111 (239)

Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors [PDF]

open access: yes, 2008
OBJECTIVE: To test the hypothesis that extracorporeal therapy with polymyxin B (PMX-B) may prevent Gram-negative sepsis-induced acute renal failure (ARF) by reducing the activity of proapoptotic circulating factors.
Segoloni GP   +13 more
core  

[Study on polymyxin B].

open access: yesThe Japanese journal of antibiotics, 1968
UEDA, YASUSHI   +6 more
openaire   +2 more sources

Rational use of intravenous polymyxin B and colistin: a review [PDF]

open access: yes, 2018
Polymyxin B and colistin (polymyxin E) were introduced in clinical practice to treat Gram-negative infections in 1950s but their parenteral use waned in 1970s due to toxicity concerns.
Mohd Nazirul Mubin bin Puteh Ahmad
core  

Polymyxin B: Controlled biosynthesis.

open access: yesThe Journal of Antibiotics, 1976
L, Withander, H, Heding
openaire   +3 more sources

Marine Antimicrobial Peptide as a Promising Alternative to Polymyxin B. [PDF]

open access: yesMar Drugs
Safronova VN   +16 more
europepmc   +1 more source

Bacterial extracellular vesicles promote membrane repair and tolerance to polymyxin B. [PDF]

open access: yesSci Adv
Bos J   +5 more
europepmc   +1 more source

Case Commentary: Intraventricular polymyxin B-small steps, big questions. [PDF]

open access: yesAntimicrob Agents Chemother
Kunnathu Puthanveedu ND, Bhimraj A.
europepmc   +1 more source

Removal of activated neutrophils by a polymyxin B-immobilized fiber (PMX) column. [PDF]

open access: yesInt J Artif Organs
Miyamoto Y   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy